Jyothy Labs raises buyback price to Rs 240 and cuts shares

Jyothy Labs Limited increased its buyback price to Rs 240 per share from Rs 215 on November 9, 2026, while retaining a maximum outlay of Rs 147 crore and reducing the proposed repurchase to 61.25 lakh shares. The revision applies to the tender offer approved by the Board on November 4, 2026.

What changed in the Jyothy Labs buyback?

Jyothy Labs raised the cash consideration by Rs 25 per equity share and reduced the maximum quantity by 7,12,210 shares without changing the Rs 147 crore buyback size. The Buyback Committee approved the revised terms on November 9 under Regulation 5(via) of the Securities and Exchange Board of India, or SEBI, Buyback Regulations.

The original November 4 approval covered up to 68,37,210 equity shares at Rs 215 each, while the revised proposal covers up to 61.25 lakh shares at Rs 240 each. The revised cap represents up to 1.67% of Jyothy Labs’ paid-up equity share capital as of March 31, 2026, compared with 1.86% under the original proposal.

How will the Jyothy Labs tender offer work?

Jyothy Labs will conduct the buyback through a proportionate tender offer for shareholders and beneficial owners who held equity shares on the November 11, 2026 record date. Accepted shares will be paid for in cash at Rs 240 per share, and each equity share has a face value of Rs 1.

BSE Limited will act as the designated stock exchange and provide a separate acquisition window for eligible shareholders wishing to place sell orders. Jyothy Labs said shares acquired through the offer will be extinguished after the buyback concludes, while the Rs 147 crore size excludes costs such as filing fees, brokerage, stock-exchange charges, taxes and adviser fees.

What allocation applies to Jyothy Labs small shareholders?

Jyothy Labs said small shareholders will receive the higher of their shareholding-based entitlement or 15% of the shares proposed for buyback, as required under the SEBI Buyback Regulations. This allocation applies to the revised maximum of 61.25 lakh shares and is part of the tender-offer process.

Actual acceptance will depend on the number of shares tendered in the relevant shareholder category and the entitlement process. The public announcement was dated November 5, 2026 and published on November 6, while an addendum dated November 9 was published on November 10 in Financial Express, Jansatta and Navshakti.

How is the Jyothy Labs buyback funded?

Jyothy Labs said the Rs 147 crore buyback represents 9.70% of its aggregate paid-up equity share capital and free reserves, based on audited standalone financial statements as of March 31, 2026. That is within the 10% statutory limit applicable to this Board-approved buyback, while the 61.25 lakh-share cap is below the separate 25% annual ceiling on paid-up equity capital.

The company reported cash and investments of Rs 996.56 crore as of March 31, 2026, comprising cash and cash equivalents and current and non-current investments. Jyothy Labs said funds for the buyback, including transaction costs, will come from free reserves, securities premium and other legally permitted sources, not borrowings from banks or financial institutions.

Will Jyothy Labs promoters participate in the buyback?

Jyothy Labs’ promoters and promoter group have said they do not intend to participate in the tender offer. Their aggregate holding was 23,09,34,685 equity shares, or 62.88%, on both the November 4 Board-meeting date and the November 5 public-announcement date.

Assuming full acceptance from eligible shareholders up to their entitlement, Jyothy Labs estimates that promoter and controlling-person ownership may rise to 63.95% after the buyback. The company said that potential increase would result from the reduction in outstanding shares and would not change control or the existing management structure.

What restrictions follow the Jyothy Labs buyback?

Jyothy Labs cannot issue shares or other securities from the November 4, 2026 resolution until payment is made to shareholders whose shares are accepted, except to meet existing obligations such as stock-option exercises. It also cannot issue the same kind of shares or securities for six months after completion, apart from bonus shares or securities issued for vested stock-option obligations.

Unless a regulatory relaxation applies, Jyothy Labs cannot raise further capital for one year after the buyback period expires, except for subsisting obligations. The company must complete the buyback within one year of November 4, 2026, cannot make another buyback offer for one year after this offer expires, and said its post-buyback debt ratio will remain below 2:1 on a standalone basis.

Conclusion

Jyothy Labs has retained its Rs 147 crore cash commitment while increasing the tender price to Rs 240 and lowering the maximum repurchase to 61.25 lakh shares. The revision reduces the maximum proportion of paid-up share capital covered by the offer to 1.67% from 1.86%, while promoters’ stated non-participation could raise their ownership from 62.88% if the offer receives the assumed response.

The next disclosed matters to watch are the tender process through BSE’s acquisition window, any further notices or corrigenda, and completion within one year of the November 4, 2026 Board resolution. The final acceptance outcome will determine the shares extinguished and the actual post-buyback ownership change.